Premium Nahrungsergänzungsmittel | artgerecht

Insulin Duration of Action – Types, Duration & Factors

Insulin duration of action describes how long an insulin preparation lowers blood glucose. It varies by insulin type and is essential for diabetes therapy planning.

Regular tips about health Regular tips about health

Things worth knowing about "Insulin Duration of Action"

Insulin duration of action describes how long an insulin preparation lowers blood glucose. It varies by insulin type and is essential for diabetes therapy planning.

What Is Insulin Duration of Action?

The insulin duration of action refers to the period during which an injected insulin preparation exerts its blood glucose-lowering effect. It is a key characteristic of every insulin type and significantly influences how and when insulin is used in the treatment of diabetes mellitus. In addition to duration of action, the onset of action and the peak effect are equally important parameters in therapy planning.

Insulin Types and Their Duration of Action

Insulin is classified into several categories that differ in onset, peak, and duration of action:

Short-Acting Insulins (Regular Insulin)

Onset: 30–60 minutes after injection
Peak: 2–4 hours
Duration: 5–8 hours
Typical use: Mealtime insulin, injected 20–30 minutes before eating

Rapid-Acting Insulin Analogues

Onset: 10–20 minutes after injection
Peak: 1–2 hours
Duration: 3–5 hours
Examples: Insulin lispro, insulin aspart, insulin glulisine
Typical use: Can be injected immediately before or after meals

Intermediate-Acting Insulins (NPH Insulin)

Onset: 1–2 hours after injection
Peak: 4–8 hours
Duration: 10–18 hours
Typical use: Basal insulin coverage, usually administered 1–2 times daily

Long-Acting Insulin Analogues

Onset: 1–4 hours after injection
Peak: Minimal or no pronounced peak (flat profile)
Duration: 20–42 hours
Examples: Insulin glargine, insulin detemir, insulin degludec
Typical use: Basal insulin to provide steady background coverage

Premixed Insulins

Combinations of short-acting and intermediate-acting insulins
Duration varies depending on the mixing ratio
Typical use: Simplified regimen, often administered twice daily

Factors Influencing Insulin Duration of Action

The actual duration of action of an insulin preparation can vary from person to person and from situation to situation. The following factors influence insulin duration:

Injection site: Insulin is absorbed fastest from the abdomen, slower from the thigh or buttock
Injection depth: Intramuscular injections accelerate absorption
Blood flow: Heat, massage, or physical activity promote absorption and may shorten duration
Insulin dose: Higher doses may result in a longer duration of action
Individual metabolic status: Insulin resistance, kidney function, and hormonal balance all affect insulin action
Temperature: Cold slows down insulin absorption

Clinical Relevance of Insulin Duration of Action

A thorough understanding of insulin duration of action is essential for safe and effective diabetes management. Errors in timing insulin injections relative to meals can lead to dangerous hypoglycemia (low blood sugar) or persistently elevated blood glucose levels (hyperglycemia). In the context of intensified insulin therapy (basal-bolus regimen), long-acting insulins provide background coverage while rapid-acting insulins are used at mealtimes. Understanding the duration of each insulin type is indispensable in this approach.

Insulin Duration in Special Situations

In certain situations, the insulin duration of action may deviate considerably from standard values:

Physical activity: Exercise increases insulin sensitivity and may prolong or intensify the effect
Illness: Fever or infections can alter insulin requirements
Pregnancy: Insulin needs and duration of action may change throughout pregnancy
Renal insufficiency: Slowed insulin clearance can extend the duration of action

References

American Diabetes Association: Standards of Medical Care in Diabetes. Diabetes Care, 2024; 47(Suppl. 1).
Skyler J.S. et al.: Differentiation of Insulin Pharmacokinetics and Pharmacodynamics. Journal of Diabetes Science and Technology, 2021.
World Health Organization (WHO): Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia. WHO Press, Geneva, 2006.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category